Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BioPharma Credit PLC BOPCF

Set alert

Price alert · BOPCF

All alert types
0.93 USD +0.93 +1,722,172,741,623,885,000.00%

At close · Aug 28

1.01 Day range 1.01
0.8503 52-week range 1.02
YTD
+8.93%
1 year
-1.17%
Open
1.01
Prev close
0.00
Mkt cap
1.04B
Vol
376
Avg vol
33.39K
EPS
0.062
P/E
14.94
More statistics
Low
1.01
High
1.01

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for BOPCF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

36.12 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 7.7×
FY 2017: 31.9×FY 2018: 14.1×FY 2019: 11.5×FY 2020: 15.1×FY 2021: 15.5×FY 2022: 7.0×FY 2023: 11.5×FY 2024: 8.1×FY 2025: 7.7×
FY 2017 5y median 8.1× FY 2025
P/S 6.9×
FY 2017: 25.8×FY 2018: 12.6×FY 2019: 11.3×FY 2020: 14.7×FY 2021: 15.0×FY 2022: 6.7×FY 2023: 9.2×FY 2024: 8.0×FY 2025: 6.9×
FY 2017 5y median 8.0× FY 2025
P/B 0.8×
FY 2017: 0.9×FY 2018: 0.7×FY 2019: 1.0×FY 2020: 1.0×FY 2021: 1.0×FY 2022: 0.9×FY 2023: 0.9×FY 2024: 0.8×FY 2025: 0.8×
FY 2017 5y median 0.9× FY 2025
P/FCF 10.6×
FY 2017: 37.6×FY 2018: 14.7×FY 2019: 10.7×FY 2020: 23.2×FY 2021: 13.7×FY 2022: 6.7×FY 2023: 10.1×FY 2024: 8.9×FY 2025: 10.6×
FY 2017 5y median 10.1× FY 2025
EV/EBITDA 7.4×
FY 2017: 19.0×FY 2018: 8.4×FY 2019: 9.0×FY 2020: 12.9×FY 2021: 14.4×FY 2022: 6.1×FY 2023: 10.7×FY 2024: 8.1×FY 2025: 7.4×
FY 2017 5y median 8.1× FY 2025
EV/Sales 6.8×
FY 2017: 15.3×FY 2018: 7.9×FY 2019: 8.9×FY 2020: 12.6×FY 2021: 13.9×FY 2022: 6.1×FY 2023: 8.5×FY 2024: 7.9×FY 2025: 6.8×
FY 2017 5y median 7.9× FY 2025
FCF Yield 9.4%
FY 2017: 2.7%FY 2018: 6.8%FY 2019: 9.4%FY 2020: 4.3%FY 2021: 7.3%FY 2022: 14.8%FY 2023: 9.9%FY 2024: 11.3%FY 2025: 9.4%
FY 2017 5y median 9.9% FY 2025

Profitability

Gross Margin 81.7%
FY 2017: 100.0%FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 81.7%
FY 2017 5y median 100.0% FY 2025
Operating Margin 92.6%
FY 2017: 80.6%FY 2018: 89.1%FY 2019: 98.6%FY 2020: 97.6%FY 2021: 96.6%FY 2022: 99.0%FY 2023: 79.9%FY 2024: 98.2%FY 2025: 92.6%
FY 2017 5y median 96.6% FY 2025
Net Margin 92.6%
FY 2017: 80.7%FY 2018: 89.1%FY 2019: 98.6%FY 2020: 97.6%FY 2021: 96.6%FY 2022: 99.0%FY 2023: 79.9%FY 2024: 98.2%FY 2025: 92.6%
FY 2017 5y median 96.6% FY 2025
ROE 11.3%
FY 2017: 2.9%FY 2018: 5.1%FY 2019: 8.7%FY 2020: 6.5%FY 2021: 6.2%FY 2022: 13.6%FY 2023: 8.1%FY 2024: 10.3%FY 2025: 11.3%
FY 2017 5y median 10.3% FY 2025
ROIC 11.1%
FY 2017: 2.9%FY 2018: 5.1%FY 2019: 8.7%FY 2020: 6.5%FY 2021: 6.2%FY 2022: 13.6%FY 2023: 8.1%FY 2024: 10.6%FY 2025: 11.1%
FY 2017 5y median 10.6% FY 2025
ROA 11.1%
FY 2017: 2.9%FY 2018: 5.0%FY 2019: 8.6%FY 2020: 6.4%FY 2021: 6.2%FY 2022: 13.4%FY 2023: 8.0%FY 2024: 10.2%FY 2025: 11.1%
FY 2017 5y median 10.2% FY 2025

Growth (YoY)

Revenue 12.7%
FY 2017: 0.0%FY 2018: 133.9%FY 2019: 57.7%FY 2020: -26.4%FY 2021: -3.7%FY 2022: 109.4%FY 2023: -26.3%FY 2024: -8.3%FY 2025: 12.7%
FY 2017 FY 2025
Operating Income 6.3%
FY 2017: 0.0%FY 2018: 158.6%FY 2019: 74.4%FY 2020: -27.1%FY 2021: -4.7%FY 2022: 114.6%FY 2023: -40.5%FY 2024: 12.7%FY 2025: 6.3%
FY 2017 FY 2025
EPS (diluted) 10.0%
FY 2017: 0.0%FY 2018: 100.3%FY 2019: 25.5%FY 2020: -27.1%FY 2021: -4.8%FY 2022: 110.4%FY 2023: -36.3%FY 2024: 20.8%FY 2025: 10.0%
FY 2017 FY 2025
Free Cash Flow -18.6%
FY 2017: 0.0%FY 2018: 191.0%FY 2019: 95.9%FY 2020: -55.8%FY 2021: 66.1%FY 2022: 91.1%FY 2023: -33.2%FY 2024: -9.1%FY 2025: -18.6%
FY 2017 FY 2025

Financial Health

Current Ratio 0.0×
FY 2017: 122×FY 2018: 70.7×FY 2019: 12.8×FY 2020: 20.6×FY 2021: 16.5×FY 2022: 5.3×FY 2023: 9.8×FY 2024: 0.3×FY 2025: 0.0×
FY 2017 5y median 5.3× FY 2025
Quick Ratio 0.0×
FY 2017: 122×FY 2018: 70.7×FY 2019: 12.8×FY 2020: 20.6×FY 2021: 16.5×FY 2022: 5.3×FY 2023: 9.8×FY 2024: 0.3×FY 2025: 0.0×
FY 2017 5y median 5.3× FY 2025
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA -0.1×
FY 2017: -12.9×FY 2018: -4.9×FY 2019: -2.4×FY 2020: -2.2×FY 2021: -1.1×FY 2022: -0.7×FY 2023: -0.8×FY 2024: -0.0×FY 2025: -0.1×
FY 2017 5y median -0.7× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 23383×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 11.4%
FY 2017: 0.8%FY 2018: 7.5%FY 2019: 7.0%FY 2020: 8.5%FY 2021: 7.6%FY 2022: 12.6%FY 2023: 7.2%FY 2024: 17.6%FY 2025: 11.4%
FY 2017 5y median 11.4% FY 2025
Payout Ratio 85.0%
FY 2017: 24.0%FY 2018: 105.6%FY 2019: 80.6%FY 2020: 127.8%FY 2021: 117.9%FY 2022: 85.9%FY 2023: 82.8%FY 2024: 143.0%FY 2025: 85.0%
FY 2017 5y median 85.9% FY 2025

Annual · latest fiscal year ends 2025-12-31